This Persistence Market Research (PMR) report examines the global market for surgical hemostats, internal tissue sealants, and adhesion barriers for the period 2017-2025. The primary objective of the report is to offer updates and information related to market opportunities in the Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market. Primary factors fuelling demand for surgical hemostats, internal tissue sealants and adhesion barriers are rapidly ageing population with rising cardiovascular, digestive, orthopaedic and other surgical procedures, strong healthcare consciousness and availability of new surgical adhesives for various surgical application.
Other factors driving demand for orthopaedic procedures are rising aging population, new demand for natural surgical surgical hemostats, internal tissue sealants and adhesion barriers with advanced technology, expansion of product in the developing regions with greater efficacy among end users and growing concerns for blood loss during surgical procedures. Availability of multiple surgical hemostats, internal tissue sealants and adhesion barriers and manufacturing of novel products such as new fibrin and collagen or thrombin based sealants with high quality tissue closure strength is expected to bolster growth of the surgical hemostats, internal tissue sealants and adhesion barriers market in the near future. Also, rising adoption of surgical hemostats, internal tissue sealants and adhesion barriers in developing countries, increasing rate of surgical procedures in developed nations with new advanced techniques and product innovation is expected to drive growth of surgical hemostats, internal tissue sealants and adhesion barriers market during the forecast period.
The market is currently is witnessing a gradual shift towards advanced biological tissue adhesives from conventional synthetic adhesives used in surgical procedures.
The surgical hemostats, internal tissue sealants and adhesion barriers market segmented as follows:
- Surgical hemostats, internal tissue sealants and adhesion barriers Market, by product type
- Surgical hemostats, internal tissue sealants and adhesion barriers Market, by application
- Surgical hemostats, internal tissue sealants and adhesion barriers Market, by end user
- Surgical hemostats, internal tissue sealants and adhesion barriers Market, by region
This report covers the global surgical hemostats, internal tissue sealants and adhesion barriers market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints and opportunities, which are influencing growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.
The surgical hemostats, internal tissue sealants and adhesion barriers market report begins with an overview of the surgical hemostats, internal tissue sealants and adhesion barriers and its definitions. This section also underlines factors influencing growth of the surgical hemostats, internal tissue sealants and adhesion barriers market along with detailing of the key trends, drivers, restraints, and opportunities. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in report to better equip clients with information and hidden insights. At the end of the report, PMR has provided key strategic recommendation for both existing and new players in the market to emerge sustainably profitable.
The global surgical hemostats, internal tissue sealants and adhesion barriers market is segmented based on product type into hemostats, internal tissue sealants and adhesion barriers. Based on application, the market has been segmented into surgical repair applications and trauma cases. Based on end user, the market has been segmented into hospitals, specialty clinics and ambulatory surgical centres. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. In terms of product type, synthetic surgical hemostats, internal tissue sealants and adhesion barriers are expected to remain in dominant position owing to its functional benefits. Synthetic surgical hemostats, internal tissue sealants and adhesion barriers are expected grow at significant rate over the forecast period.
The next section of the report highlights the growth trends of the surgical hemostats, internal tissue sealants and adhesion barriers market by regions. It provides a market outlook for 2017-2025 and sets the forecast within the context of the surgical hemostats, internal tissue sealants and adhesion barriers market. The study discusses key regional trends contributing to growth of the surgical hemostats, internal tissue sealants and adhesion barriers market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA. North America region is expected to emerge dominant and most attractive over the forecast period.
The above sections - by product type, by application, by end user and by region - evaluate the present scenario and growth prospects of the surgical hemostats, internal tissue sealants and adhesion barriers market for the period 2017-2025. 2016 has been considered the base year, providing the reference data for projections throughout the forecast period. Detailed company profiles include company-specific long-term and short-term strategies, key offerings and recent developments in the surgical hemostats, internal tissue sealants and adhesion barriers market. Key competitors covered in terms of manufacturers include Pfizer, Sanofi S.A., Cryolife, Baxter International Inc., Braun Melsungen AG, Johnson and Johnson, Cohera Medical, Inc., Tissuemed Ltd., C.R. Bard Inc., Integra LifeSciences Corporation.
Table of Contents
1. Executive Summary
- 1.1. Market Overview
- 1.2. Market Analysis
- 1.3. PMR Analysis and Recommendations
- 1.4. Wheel of Fortune
2. Market Introduction
- 2.1. Market Definition
- 2.2. Market Taxonomy
- 2.3. Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Overview
3. Market View Point
- 3.1. Macro-Economic Factors
- 3.2. Opportunity Analysis
- 3.3. Reimbursement Scenario
4. North America Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025
- 4.1. Introduction
- 4.2. Key Regulations
- 4.3. Regional Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Trends
- 4.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
- 4.4.1. U.S.
- 4.4.2. Canada
- 4.5. Market Size (US$ Mn) and Forecast By Country, 2017-2025
- 4.5.1. U.S.
- 4.5.2. Canada
- 4.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 4.6.1. Hemostats
- 4.6.1.1. Thrombin Based
- 4.6.1.2. Combination
- 4.6.1.3. Oxidized Regenerated Cellulose Based
- 4.6.1.4. Gelatin Based
- 4.6.1.5. Collagen Based
- 4.6.2. Internal Tissue Sealants
- 4.6.2.1. Fibrin Based
- 4.6.2.2. Collagen Based
- 4.6.2.3. Protein Based
- 4.6.2.4. Synthetic
- 4.6.3. Adhesion Barriers
- 4.6.3.1. Film Based
- 4.6.3.2. Gel Based
- 4.6.3.3. Solution Based
- 4.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 4.7.1. Hemostats
- 4.7.1.1. Thrombin Based
- 4.7.1.2. Combination
- 4.7.1.3. Oxidized Regenerated Cellulose Based
- 4.7.1.4. Gelatin Based
- 4.7.1.5. Collagen Based
- 4.7.2. Internal Tissue Sealants
- 4.7.2.1. Fibrin Based
- 4.7.2.2. Collagen Based
- 4.7.2.3. Protein Based
- 4.7.2.4. Synthetic
- 4.7.3. Adhesion Barriers
- 4.7.3.1. Film Based
- 4.7.3.2. Gel Based
- 4.7.3.3. Solution Based
- 4.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
- 4.8.1. Surgical Repair
- 4.8.1.1. Cardiovascular
- 4.8.1.2. Neurological
- 4.8.1.3. Orthopedic
- 4.8.1.4. Urological
- 4.8.1.5. General Surgeries
- 4.8.1.6. Reconstructive
- 4.8.1.7. Others
- 4.8.2. Trauma cases
- 4.9. Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 4.9.1. Surgical Repair
- 4.9.1.1. Cardiovascular
- 4.9.1.2. Neurological
- 4.9.1.3. Orthopedic
- 4.9.1.4. Urological
- 4.9.1.5. General Surgeries
- 4.9.1.6. Reconstructive
- 4.9.1.7. Others
- 4.9.2. Trauma cases
- 4.10. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 4.10.1. Hospitals
- 4.10.2. Ambulatory Surgical Centers
- 4.10.3. Specialty Clinics
- 4.11.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 4.11.1. Hospitals
- 4.11.2. Ambulatory Surgical Centers
- 4.11.3. Specialty Clinics
- 4.12. Drivers and Restraints: Impact Analysis
- 4.13. Market Attractiveness Analysis
- 4.13.1. By Country
- 4.13.2. By Product Type
- 4.13.3. By Application
- 4.13.4. By End User
- 4.14.Key Representative Market Participants
- 4.15.Key Participants Market Presence (Intensity Map)
5. Latin America Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025
- 5.1. Introduction
- 5.2. Key Regulations
- 5.3. Regional Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Trends
- 5.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
- 5.4.1. Brazil
- 5.4.2. Mexico
- 5.4.3. Rest of Latin America
- 5.5. Market Size (US$ Mn) and Forecast By Country, 2017-2025
- 5.5.1. Brazil
- 5.5.2. Mexico
- 5.5.3. Rest of Latin America
- 5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 5.6.1. Hemostats
- 5.6.1.1. Thrombin Based
- 5.6.1.2. Combination
- 5.6.1.3. Oxidized Regenerated Cellulose Based
- 5.6.1.4. Gelatin Based
- 5.6.1.5. Collagen Based
- 5.6.2. Internal Tissue Sealants
- 5.6.2.1. Fibrin Based
- 5.6.2.2. Collagen Based
- 5.6.2.3. Protein Based
- 5.6.2.4. Synthetic
- 5.6.3. Adhesion Barriers
- 5.6.3.1. Film Based
- 5.6.3.2. Gel Based
- 5.6.3.3. Solution Based
- 5.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 5.7.1. Hemostats
- 5.7.1.1. Thrombin Based
- 5.7.1.2. Combination
- 5.7.1.3. Oxidized Regenerated Cellulose Based
- 5.7.1.4. Gelatin Based
- 5.7.1.5. Collagen Based
- 5.7.2. Internal Tissue Sealants
- 5.7.2.1. Fibrin Based
- 5.7.2.2. Collagen Based
- 5.7.2.3. Protein Based
- 5.7.2.4. Synthetic
- 5.7.3. Adhesion Barriers
- 5.7.3.1. Film Based
- 5.7.3.2. Gel Based
- 5.7.3.3. Solution Based
- 5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
- 5.8.1. Surgical Repair
- 5.8.1.1. Cardiovascular
- 5.8.1.2. Neurological
- 5.8.1.3. Orthopedic
- 5.8.1.4. Urological
- 5.8.1.5. General Surgeries
- 5.8.1.6. Reconstructive
- 5.8.1.7. Others
- 5.8.2. Trauma cases
- 5.9. Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 5.9.1. Surgical Repair
- 5.9.1.1. Cardiovascular
- 5.9.1.2. Neurological
- 5.9.1.3. Orthopedic
- 5.9.1.4. Urological
- 5.9.1.5. General Surgeries
- 5.9.1.6. Reconstructive
- 5.9.1.7. Others
- 5.9.2. Trauma cases
- 5.10.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 5.10.1. Hospitals
- 5.10.2. Ambulatory Surgical Centers
- 5.10.3. Specialty Clinics
- 5.11.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 5.11.1. Hospitals
- 5.11.2. Ambulatory Surgical Centers
- 5.11.3. Specialty Clinics
- 5.12.Drivers and Restraints: Impact Analysis
- 5.13.Market Attractiveness Analysis
- 5.13.1. By Country
- 5.13.2. By Product Type
- 5.13.3. By Application
- 5.13.4. By End User
- 5.14.Key Representative Market Participants
- 5.15.Key Participants Market Presence (Intensity Map)
6. Europe Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025
- 6.1. Introduction
- 6.2. Key Regulations
- 6.3. Regional Market Dynamics
- 6.3.1. Drivers
- 6.3.2. Restraints
- 6.3.3. Trends
- 6.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Spain
- 6.4.5. Italy
- 6.4.6. BENELUX
- 6.4.7. Russia
- 6.4.8. Rest of Europe
- 6.5. Market Size (US$ Mn) and Forecast By Country, 2017-2025
- 6.5.1. Germany
- 6.5.2. France
- 6.5.3. U.K.
- 6.5.4. Spain
- 6.5.5. Italy
- 6.5.6. BENELUX
- 6.5.7. Russia
- 6.5.8. Rest of Europe
- 6.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 6.6.1. Hemostats
- 6.6.1.1. Thrombin Based
- 6.6.1.2. Combination
- 6.6.1.3. Oxidized Regenerated Cellulose Based
- 6.6.1.4. Gelatin Based
- 6.6.1.5. Collagen Based
- 6.6.2. Internal Tissue Sealants
- 6.6.2.1. Fibrin Based
- 6.6.2.2. Collagen Based
- 6.6.2.3. Protein Based
- 6.6.2.4. Synthetic
- 6.6.3. Adhesion Barriers
- 6.6.3.1. Film Based
- 6.6.3.2. Gel Based
- 6.6.3.3. Solution Based
- 6.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 6.7.1. Hemostats
- 6.7.1.1. Thrombin Based
- 6.7.1.2. Combination
- 6.7.1.3. Oxidized Regenerated Cellulose Based
- 6.7.1.4. Gelatin Based
- 6.7.1.5. Collagen Based
- 6.7.2. Internal Tissue Sealants
- 6.7.2.1. Fibrin Based
- 6.7.2.2. Collagen Based
- 6.7.2.3. Protein Based
- 6.7.2.4. Synthetic
- 6.7.3. Adhesion Barriers
- 6.7.3.1. Film Based
- 6.7.3.2. Gel Based
- 6.7.3.3. Solution Based
- 6.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
- 6.8.1. Surgical Repair
- 6.8.1.1. Cardiovascular
- 6.8.1.2. Neurological
- 6.8.1.3. Orthopedic
- 6.8.1.4. Urological
- 6.8.1.5. General Surgeries
- 6.8.1.6. Reconstructive
- 6.8.1.7. Others
- 6.8.2. Trauma cases
- 6.9. Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 6.9.1. Surgical Repair
- 6.9.1.1. Cardiovascular
- 6.9.1.2. Neurological
- 6.9.1.3. Orthopedic
- 6.9.1.4. Urological
- 6.9.1.5. General Surgeries
- 6.9.1.6. Reconstructive
- 6.9.1.7. Others
- 6.9.2. Trauma cases
- 6.10.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 6.10.1. Hospitals
- 6.10.2. Ambulatory Surgical Centers
- 6.10.3. Specialty Clinics
- 6.11.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 6.11.1. Hospitals
- 6.11.2. Ambulatory Surgical Centers
- 6.11.3. Specialty Clinics
- 6.12.Drivers and Restraints: Impact Analysis
- 6.13.Market Attractiveness Analysis
- 6.13.1. By Country
- 6.13.2. By Product Type
- 6.13.3. By Application
- 6.13.4. By End User
- 6.14.Key Representative Market Participants
- 6.15.Key Participants Market Presence (Intensity Map)
7. Asia Pacific Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025
- 7.1. Introduction
- 7.2. Key Regulations
- 7.3. Regional Market Dynamics
- 7.3.1. Drivers
- 7.3.2. Restraints
- 7.3.3. Trends
- 7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
- 7.4.1. China
- 7.4.2. India
- 7.4.3. Australia and New Zealand
- 7.4.4. ASEAN
- 7.4.5. Rest of ASIA PACIFIC
- 7.5. Market Size (US$ Mn) and Forecast By Country, 2017-2025
- 7.5.1. China
- 7.5.2. India
- 7.5.3. Australia and New Zealand
- 7.5.4. ASEAN
- 7.5.5. Rest of Asia Pacific
- 7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 7.6.1. Hemostats
- 7.6.1.1. Thrombin Based
- 7.6.1.2. Combination
- 7.6.1.3. Oxidized Regenerated Cellulose Based
- 7.6.1.4. Gelatin Based
- 7.6.1.5. Collagen Based
- 7.6.2. Internal Tissue Sealants
- 7.6.2.1. Fibrin Based
- 7.6.2.2. Collagen Based
- 7.6.2.3. Protein Based
- 7.6.2.4. Synthetic
- 7.6.3. Adhesion Barriers
- 7.6.3.1. Film Based
- 7.6.3.2. Gel Based
- 7.6.3.3. Solution Based
- 7.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 7.7.1. Hemostats
- 7.7.1.1. Thrombin Based
- 7.7.1.2. Combination
- 7.7.1.3. Oxidized Regenerated Cellulose Based
- 7.7.1.4. Gelatin Based
- 7.7.1.5. Collagen Based
- 7.7.2. Internal Tissue Sealants
- 7.7.2.1. Fibrin Based
- 7.7.2.2. Collagen Based
- 7.7.2.3. Protein Based
- 7.7.2.4. Synthetic
- 7.7.3. Adhesion Barriers
- 7.7.3.1. Film Based
- 7.7.3.2. Gel Based
- 7.7.3.3. Solution Based
- 7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
- 7.8.1. Surgical Repair
- 7.8.1.1. Cardiovascular
- 7.8.1.2. Neurological
- 7.8.1.3. Orthopedic
- 7.8.1.4. Urological
- 7.8.1.5. General Surgeries
- 7.8.1.6. Reconstructive
- 7.8.1.7. Others
- 7.8.2. Trauma cases
- 7.9. Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 7.9.1. Surgical Repair
- 7.9.1.1. Cardiovascular
- 7.9.1.2. Neurological
- 7.9.1.3. Orthopedic
- 7.9.1.4. Urological
- 7.9.1.5. General Surgeries
- 7.9.1.6. Reconstructive
- 7.9.1.7. Others
- 7.9.2. Trauma cases
- 7.10.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 7.10.1. Hospitals
- 7.10.2. Ambulatory Surgical Centers
- 7.10.3. Specialty Clinics
- 7.11.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 7.11.1. Hospitals
- 7.11.2. Ambulatory Surgical Centers
- 7.11.3. Specialty Clinics
- 7.12.Drivers and Restraints: Impact Analysis
- 7.13.Market Attractiveness Analysis
- 7.13.1. By Country
- 7.13.2. By Product Type
- 7.13.3. By Application
- 7.13.4. By End User
- 7.14.Key Representative Market Participants
- 7.15.Key Participants Market Presence (Intensity Map)
8. MEA Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025
- 8.1. Introduction
- 8.2. Key Regulations
- 8.3. Regional Market Dynamics
- 8.3.1. Drivers
- 8.3.2. Restraints
- 8.3.3. Trends
- 8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
- 8.4.1. GCC Countries
- 8.4.2. South Africa
- 8.4.3. Rest of MEA
- 8.5. Market Size (US$ Mn) and Forecast By Country, , 2017-2025
- 8.5.1. GCC Countries
- 8.5.2. South Africa
- 8.5.3. Rest of MEA
- 8.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 8.6.1. Hemostats
- 8.6.1.1. Thrombin Based
- 8.6.1.2. Combination
- 8.6.1.3. Oxidized Regenerated Cellulose Based
- 8.6.1.4. Gelatin Based
- 8.6.1.5. Collagen Based
- 8.6.2. Internal Tissue Sealants
- 8.6.2.1. Fibrin Based
- 8.6.2.2. Collagen Based
- 8.6.2.3. Protein Based
- 8.6.2.4. Synthetic
- 8.6.3. Adhesion Barriers
- 8.6.3.1. Film Based
- 8.6.3.2. Gel Based
- 8.6.3.3. Solution Based
- 8.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 8.7.1. Hemostats
- 8.7.1.1. Thrombin Based
- 8.7.1.2. Combination
- 8.7.1.3. Oxidized Regenerated Cellulose Based
- 8.7.1.4. Gelatin Based
- 8.7.1.5. Collagen Based
- 8.7.2. Internal Tissue Sealants
- 8.7.2.1. Fibrin Based
- 8.7.2.2. Collagen Based
- 8.7.2.3. Protein Based
- 8.7.2.4. Synthetic
- 8.7.3. Adhesion Barriers
- 8.7.3.1. Film Based
- 8.7.3.2. Gel Based
- 8.7.3.3. Solution Based
- 8.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
- 8.8.1. Surgical Repair
- 8.8.1.1. Cardiovascular
- 8.8.1.2. Neurological
- 8.8.1.3. Orthopedic
- 8.8.1.4. Urological
- 8.8.1.5. General Surgeries
- 8.8.1.6. Reconstructive
- 8.8.1.7. Others
- 8.8.2. Trauma cases
- 8.9. Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 8.9.1. Surgical Repair
- 8.9.1.1. Cardiovascular
- 8.9.1.2. Neurological
- 8.9.1.3. Orthopedic
- 8.9.1.4. Urological
- 8.9.1.5. General Surgeries
- 8.9.1.6. Reconstructive
- 8.9.1.7. Others
- 8.9.2. Trauma cases
- 8.10.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 8.10.1. Hospitals
- 8.10.2. Ambulatory Surgical Centers
- 8.10.3. Specialty Clinics
- 8.11.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 8.11.1. Hospitals
- 8.11.2. Ambulatory Surgical Centers
- 8.11.3. Specialty Clinics
- 8.12.Drivers and Restraints: Impact Analysis
- 8.13.Market Attractiveness Analysis
- 8.13.1. By Country
- 8.13.2. By Product Type
- 8.13.3. By Application
- 8.13.4. By End User
- 8.14.Key Representative Market Participants
- 8.15.Key Participants Market Presence (Intensity Map)
9. Forecast Factors: Relevance and Impact
10. Forecast Assumptions
11. Competition Landscape
- 11.1.Market Structure
- 11.2.Competition Intensity Mapping By Market Taxonomy
- 11.3.Competition Dashboard
- 11.4.Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.4.1. Baxter
- 11.4.2. Ethicon, Inc.
- 11.4.3. B. Braun Melsungen AG
- 11.4.4. Sanofi
- 11.4.5. C. R. Bard, Inc.
- 11.4.6. Integra Lifesciences Corporation
- 11.4.7. Cryolife Inc.
- 11.4.8. Tissuemed Ltd
- 11.4.9. Cohera Medical, Inc.
- 11.4.10. Pfizer Inc.
12. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025, By Region
- 12.1.Introduction / Key Findings
- 12.2.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
- 12.2.1. North America
- 12.2.2. Latin America
- 12.2.3. Europe
- 12.2.4. Asia Pacific
- 12.2.5. MEA
- 12.3.Market Size (US$ Mn) Forecast By Region, 2017-2025
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Asia Pacific
- 12.3.5. MEA
- 12.4.Market Attractiveness Analysis By Region
13. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
- 13.1.Introduction
- 13.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
- 13.2.1. Hemostats
- 13.2.1.1. Thrombin Based
- 13.2.1.2. Combination
- 13.2.1.3. Oxidized Regenerated Cellulose Based
- 13.2.1.4. Gelatin Based
- 13.2.1.5. Collagen Based
- 13.2.2. Internal Tissue Sealants
- 13.2.2.1. Fibrin Based
- 13.2.2.2. Collagen Based
- 13.2.2.3. Protein Based
- 13.2.2.4. Synthetic
- 13.2.3. Adhesion Barriers
- 13.2.3.1. Film Based
- 13.2.3.2. Gel Based
- 13.2.3.3. Solution Based
- 13.3.Market Size (US$ Mn) Forecast By Product Type, 2017-2025
- 13.3.1. Hemostats
- 13.3.1.1. Thrombin Based
- 13.3.1.2. Combination
- 13.3.1.3. Oxidized Regenerated Cellulose Based
- 13.3.1.4. Gelatin Based
- 13.3.1.5. Collagen Based
- 13.3.2. Internal Tissue Sealants
- 13.3.2.1. Fibrin Based
- 13.3.2.2. Collagen Based
- 13.3.2.3. Protein Based
- 13.3.2.4. Synthetic
- 13.3.3. Adhesion Barriers
- 13.3.3.1. Film Based
- 13.3.3.2. Gel Based
- 13.3.3.3. Solution Based
- 13.4.Key Trends / Developments
- 13.5.Market Attractiveness Analysis By Product Type
14. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025, By Application
- 14.1.Introduction
- 14.1.1. Surgical Repair
- 14.1.1.1. Cardiovascular
- 14.1.1.2. Neurological
- 14.1.1.3. Orthopedic
- 14.1.1.4. Urological
- 14.1.1.5. General Surgeries
- 14.1.1.6. Reconstructive
- 14.1.1.7. Others
- 14.1.2. Trauma cases
- 14.2.Market Size (US$ Mn) and Forecast, By Application, 2017-2025
- 14.2.1. Surgical Repair
- 14.2.1.1. Cardiovascular
- 14.2.1.2. Neurological
- 14.2.1.3. Orthopedic
- 14.2.1.4. Urological
- 14.2.1.5. General Surgeries
- 14.2.1.6. Reconstructive
- 14.2.1.7. Others
- 14.2.2. Trauma cases
- 14.3.Key Trends / Developments
- 14.4.Market Attractive Analysis By Application
15. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis 2012-2016 and Forecast 2017-2025, By End User
- 15.1.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
- 15.1.1. Hospitals
- 15.1.2. Ambulatory Surgical Centers
- 15.1.3. Specialty Clinics
- 15.2.Market Size (US$ Mn) and Forecast, By End User, 2017-2025
- 15.2.1. Hospitals
- 15.2.2. Ambulatory Surgical Centers
- 15.2.3. Specialty Clinics
- 15.3.Key Trends / Developments
- 15.4.Market Attractive Analysis By End User
16. Global Market Analysis 2012-2016 and Forecast 2017-2025
- 16.1. Market Size and Y-o-Y Growth
- 16.2. Absolute $ Opportunity
- 16.3. Value Chain
- 16.4. Research Methodology
欧州の止血剤・シーラント市場 ～2024年：ブランド (Hemopatch (Baxter)、Tachosil (武田薬品工業)、Veriset (Medtronic)、Avitene (C.R Bard)、Sangustop (B Braun)、Lyostypt (B Braun))・国別の予測
止血剤・組織シーラントの世界市場の将来予測
止血剤の世界市場：種類・用途・エンドユーザー・地域別の将来予測
止血剤の世界市場予測 ～2023年：製品（トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン）、用途（婦人科手術、神経手術、心血管手術、再建手術）、形態（マトリックス材・ゲル、シート・パッド、パウダー、ゲル）、地域別
止血剤：医療機器のパイプライン評価
世界の止血剤市場分析および動向
世界の止血剤市場：分析、企業プロファイル、規模、シェア、成長率、動向、予測
世界の外科的止血、内部組織シーラントおよび接着バリア市場調査
止血剤・組織シーラントの世界市場：2016年～2020年
インドの止血剤市場
